Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Development Of Precision Medicine
3.2. Key Drivers
3.2.1. Usage Of Digital Collaboration In Exchanging Useful Information For The Development Of Precision Medicine
3.2.2. Identification And Characterization Of Essential Genes In The Human Genome
3.2.3. Investments By Government And Private Players To Find Effective Treatment For Different Types Of Cancers
3.2.4. Prevalence Of Precision Medicine To Tackle Chronic Conditions
3.2.5. Demand For Preventive Care
3.3. Key Restraints
3.3.1. Security Risks Associated With Data Sharing
3.3.2. Difficulty In Acquiring Pharmacotherapy Approval For A New Drug
3.3.3. Uncertainty Associated With Reimbursement And Regulatory Policies

4. Key Analytics
4.1. Impact Of Covid-19 On Precision Medicine Market
4.2. Key Investment Insights
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entries
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Technologies Related To Precision Medicine
4.7. Supply Chain Analysis
4.8. Regulatory Framework

5. Market By Application
5.1. Oncology
5.2. Infectious Diseases
5.3. Neurology/Physiatry
5.4. Cardiovascular
5.5. Lifestyle And Endocrinology
5.6. Gastroenterology
5.7. Other Applications

6. Market By Component
6.1. Applied Science
6.1.1. Genomics
6.1.1.1. Pcr
6.1.1.2. Pm Ngs
6.1.1.3. Genome Editing
6.1.1.4. Other Genomics Technologies
6.1.2. Pharmacogenomics
6.1.3. Other Applied Sciences
6.2. Precision Therapeutics
6.2.1. Clinical Trials
6.2.2. Cell Therapy
6.2.3. Drug Discovery And Research
6.2.4. Gene Therapy
6.3. Precision Diagnostics
6.3.1. Molecular Diagnostics
6.3.1.1. Non-Invasive Prenatal Testing (Nipt)
6.3.1.2. Companion Diagnostics
6.3.1.3. Liquid Biopsy
6.3.1.4. Other Molecular Diagnostics
6.3.2. Medical Imaging
6.3.2.1. Imaging Analytics
6.3.2.2. Imaging Computer-Aided Detection (Cadx)
6.4. Digital Health And Information Technology
6.4.1. Clinical Decision Support Systems (Cdss)
6.4.2. Big Data Analytics
6.4.3. It Infrastructure
6.4.4. Genomics Informatics
6.4.5. In-Silico Informatics
6.4.6. Mobile Health

7. Geographical Analysis
7.1. North America
7.1.1. Market Size & Estimates
7.1.2. Key Growth Enablers
7.1.3. Key Challenges
7.1.4. Key Players
7.1.5. Country Analysis
7.1.5.1. United States
7.1.5.2. Canada

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships, Contracts/Agreements & Collaborations
8.1.4. Business Expansions/ Approvals/ Announcements
8.2. Company Profiles
8.2.1. Abbott Laboratories
8.2.2. Astra Zeneca Plc
8.2.3. Biocrates Life Sciences Ag
8.2.4. Bio-Rad Laboratories Inc
8.2.5. Danaher Corporation
8.2.6. Eagle Genomics Ltd
8.2.7. Eli Lilly & Company
8.2.8. F. Hoffmann-La Roche
8.2.9. Intomics
8.2.10. Laboratory Corporation Of America Holdings
8.2.11. Nanostring Technologies
8.2.12. Novartis Ag
8.2.13. Pfizer Inc
8.2.14. Qiagen Nv
8.2.15. Quest Diagnostics Incorporated



List of Figures


Figure 1: Chronic Conditions In Patients Hospitalized With Covid-19 In The United States
Figure 2: Key Investment Insights
Figure 3: Porter’S Five Forces Analysis
Figure 4: Opportunity Matrix
Figure 5: Vendor Landscape
Figure 6: North America Precision Medicine Market, By Application, In 2020
Figure 7: North America Precision Medicine Market, By Oncology, 2021-2028 (In $ Million)
Figure 8: North America Precision Medicine Market, By Infectious Diseases, 2021-2028 (In $ Million)
Figure 9: North America Precision Medicine Market, By Neurology/Physiatry, 2021-2028 (In $ Million)
Figure 10: North America Precision Medicine Market, By Cardiovascular, 2021-2028 (In $ Million)
Figure 11: North America Precision Medicine Market, By Lifestyle And Endocrinology, 2021-2028 (In $ Million)
Figure 12: North America Precision Medicine Market, By Gastroenterology, 2021-2028 (In $ Million)
Figure 13: North America Precision Medicine Market, By Other Applications,2021-2028 (In $ Million)
Figure 14: North America Precision Medicine Market, By Component, In 2020
Figure 15: North America Precision Medicine Market, By Applied Science, 2021-2028 (In $ Million)
Figure 16: North America Applied Science Market, By Genomics, 2021-2028 (In $ Million)
Figure 17: North America Genomics Market, By Pcr, 2021-2028 (In $ Million)
Figure 18: North America Genomics Market, By Pm Ngs, 2021-2028 (In $ Million)
Figure 19: North America Genomics Market, By Genome Editing, 2021-2028 (In $ Million)
Figure 20: North America Genomics Market, By Other Genomics Technologies, 2021-2028 (In $ Million)
Figure 21: North America Applied Science Market, By Pharmacogenomics, 2021-2028 (In $ Million)
Figure 22: Biomarker’S Role In Pharmacogenomics
Figure 23: North America Applied Sciences Market, By Other Applied Sciences, 2021-2028 (In $ Million)
Figure 24: North America Precision Medicine Market, By Precision Therapeutics, 2021-2028 (In $ Million)
Figure 25: North America Precision Therapeutics Market, By Clinical Trials, 2021-2028 (In $ Million)
Figure 26: North America Precision Therapeutics Market, By Cell Therapy, 2021-2028 (In $ Million)
Figure 27: North America Precision Therapeutics Market, By Drug Discovery And Research, 2021-2028 (In $ Million)
Figure 28: North America Precision Therapeutics Market, By Gene Therapy, 2021-2028 (In $ Million)
Figure 29: North America Precision Medicine Market, By Precision Diagnostics, 2021-2028 (In $ Million)
Figure 30: North America Precision Diagnostics Market, By Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 31: North America Molecular Diagnostics Market, By Non-Invasive Prenatal Testing (Nipt), 2021-2028 (In $ Million)
Figure 32: North America Molecular Diagnostics Market, By Companion Diagnostics, 2021-2028 (In $ Million)
Figure 33: North America Molecular Diagnostics Market, By Liquid Biopsy, 2021-2028 (In $ Million)
Figure 34: North America Molecular Diagnostics Market, By Other Molecular Diagnostics, 2021-2028 (In $ Million)
Figure 35: North America Precision Diagnostics Market, By Medical Imaging, 2021-2028 (In $ Million)
Figure 36: North America Medical Imaging Market, By Imaging Analytics, 2021-2028 (In $ Million)
Figure 37: North America Medical Imaging Market, By Imaging Computer-Aided Detection (Cadx), 2021-2028 (In $ Million)
Figure 38: North America Precision Medicine Market, By Digital Health And Information Technology, 2021-2028 (In $ Million)
Figure 39: North America Digital Health And Information Technology Market, By Clinical Decision Support Systems (Cdss), 2021-2028 (In $ Million)
Figure 40: North America Digital Health And Information Technology Market, By Big Data Analytics, 2021-2028 (In $ Million)
Figure 41: North America Digital Health And Information Technology Market, By It Infrastructure, 2021-2028 (In $ Million)
Figure 42: North America Digital Health And Information Technology Market, By Genomics Informatics, 2021-2028 (In $ Million)
Figure 43: North America Digital Health And Information Technology Market, By In-Silico Informatics, 2021-2028 (In $ Million)
Figure 44: North America Digital Health And Information Technology Market, By Mobile Health, 2021-2028 (In $ Million)
Figure 45: North America Precision Medicine Market, Country Outlook, 2020 & 2028 (In %)
Figure 46: United States Precision Medicine Market, 2021-2028 (In $ Million)
Figure 47: Canada Precision Medicine Market, 2021-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT - PRECISION MEDICINE
TABLE 2: NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA PRECISION MEDICINE MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA PRECISION MEDICINE MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA APPLIED SCIENCE MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA APPLIED SCIENCE MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA GENOMICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA GENOMICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: NORTH AMERICA PRECISION THERAPEUTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 13: NORTH AMERICA PRECISION DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 14: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 15: NORTH AMERICA MOLECULAR DIAGNOSTICS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 16: NORTH AMERICA MEDICAL IMAGING MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 17: NORTH AMERICA MEDICAL IMAGING MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 18: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: NORTH AMERICA DIGITAL HEALTH AND INFORMATION TECHNOLOGY MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: NORTH AMERICA PRECISION MEDICINE MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: LEADING PLAYERS OPERATING IN NORTH AMERICA PRECISION MEDICINE MARKET
TABLE 23: LIST OF MERGERS & ACQUISITIONS
TABLE 24: LIST OF PRODUCTS LAUNCHES & DEVELOPMENTS
TABLE 25: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 26: LIST OF BUSINESS EXPANSIONS & DIVESTITURES